Insights from the molecular docking analysis of colistin with the PmrA protein model from Acinetobacter baumannii

被引：1

作者：

Ganeshan, Shalini ^{[1
]}

Shakibaie, Mohammad Reza ^{[2
,3
]}

Rajagopal, Rajaguru ^{[4
]}

机构：

[1] Tips Coll Arts & Sci, Dept Biotechnol, Coimbatore 641107, Tamil Nadu, India

[2] Kerman Univ Med Sci, Dept Microbiol & Virol, Kerman, Iran

[3] Kerman Univ Med Sci, Environm Hlth Engn Res Ctr, Kerman, Iran

[4] Mother Theresa Post Grad & Res Inst Hlth Sci, Dept Pharmaceut, Pondicherry 605006, India

来源：

BIOINFORMATION | 2022年 / 18卷 / 01期

关键词：

Acinetobacter baumannii; protein modeling; model quality; molecular docking; RESISTANCE;

D O I：

10.6026/97320630018041

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Acinetobacter baumannii (AB) is one of the most common causes of nosocomial infections. Therefore, it is of interest to design and develop drugs against Acinetobacter baumannii. A strain of AB showing MIC 32 mu g/ml against colistin was isolated from a hospital environment in Iran. Hence, we document data to glean insights from the molecular docking analysis of colistin with the PmrA protein from this bacterium.

引用

页码：41 / 49

页数：9

共 50 条

[1] Structure of the Acinetobacter baumannii PmrA receiver domain and insights into clinical mutants affecting DNA binding and promoting colistin resistance
Palethorpe, Samantha
Milton, Morgan E.
Pesci, Everett C.
Cavanagh, John
JOURNAL OF BIOCHEMISTRY, 2021, 170 (06): : 787 - 800
[2] Colistin Resistance in Acinetobacter baumannii: Basic and Clinical Insights
Kamoshida, Go
Yamada, Noriteru
Yamaguchi, Daiki
Yahiro, Kinnosuke
Morita, Yuji
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2025, 48 (03) : 213 - 221
[3] Molecular characterization of lpxACD and pmrA/B two-component regulatory system in the colistin resistance Acinetobacter baumannii clinical isolates
Ghahraman, Mohammad Reza Kandehkar
Hosseini-Nave, Hossein
Azizi, Omid
Shakibaie, Mohammad Reza
Mollaie, Hamid Reza
Shakibaie, Samane
GENE REPORTS, 2020, 21
[4] Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
Novovic, Katarina
Jovcic, Branko
ANTIBIOTICS-BASEL, 2023, 12 (03):
[5] Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis
Rodríguez-Hernández, MJ
Jiménez-Mejias, ME
Pichardo, C
Cuberos, L
García-Curiel, A
Pachón, J
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (06) : 581 - 584
[6] Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii
Motaouakkil, Said
Charra, Boubaker
Hachimi, Abdelhamid
Nejmi, Hicham
Benslama, Abdellatif
Elmdaghri, Naima
Belabbes, Habiba
Benbachir, Mohamed
JOURNAL OF INFECTION, 2006, 53 (04) : 274 - 278
[7] Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates
Srinivas, Pavithra
Hunt, Lauren N.
Pouch, Stephanie M.
Thomas, Keelie
Goff, Debra A.
Pancholi, Preeti
Balada-Llasat, Joan-Miquel
Bauer, Karri A.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (02) : 194 - 198
[8] The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units
Farajnia, Safar
Lotfi, Fariba
Dehnad, Alireza
Shojaie, Maryam
Raisi, Roya
Rahbarnia, Leila
Bazmani, Ahad
Naghili, Behrooz
Shiry, Samaneh
IRANIAN JOURNAL OF MICROBIOLOGY, 2022, 14 (03) : 319 - 327
[9] Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
Goic-Barisic, Ivana
Music, Martina Seruga
Drcelic, Marina
Tuncbilek, Semra
Akca, Gulcin
Jakovac, Sanja
Tonkic, Marija
Hrenovic, Jasna
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 33 : 26 - 30
[10] A Systematic Review and Meta-Analysis of Molecular Characteristics on Colistin Resistance of Acinetobacter baumannii
Ciftci, Ihsan Hakki
Kilbas, Elmas Pinar Kahraman
Kilbas, Imdat
DIAGNOSTICS, 2024, 14 (22)

← 1 2 3 4 5 →